
ACAD Market Cap & Key Metrics
ACADIA Pharmaceuticals Inc.
$17.66
-$0.17(-0.98%)
50
Overall
75
Value
18
Tech
57
Quality
Market Cap
$3.05B
Volume
861.71K
52W Range
$15.86 - $30.96
Target Price
$30.05
ACAD market cap is $3.05B. This page lists ACADIA Pharmaceuticals Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
ACAD Key Metrics
- Market cap
- $3.05B
- P/E ratio (current-year EPS estimate)
- 23.23
- EPS estimate, current year
- $0.76
- EPS growth, 3-year
- +0.00%
- Value score
- 75
- Quality score
- 57
- Technical score
- 18
| Fiscal year | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|
| Revenue | $61.0K | $120.0K | $1.15M | $4.91M | $2.07M |
| EBITDA | -$165.53M | -$91.78M | -$36.34M | -$20.87M | -$22.38M |
| EPS | - | - | - | $-0.38 | $-0.44 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ACAD | $17.66 | -1.0% | 861.71K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get ACADIA Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW